Additionally, overexpression of CAMK2N1 also associated with pN1 disease, putting in evidence its effect on PCa metastization, and alterations in this gene predicted poorer disease/progression-free survival. The gene discussed is CAMK2N1; the disease is posterior cortical atrophy.